Topics:

COPD

COPD

While high-dose opioids may be deadly, lower doses may be safe for symptom reduction in severe respiratory disease. For those with milder COPD, a new treatment is in testing.

High doses of N-acetylcysteine improve small airway function in patients with COPD. The unresolved question is why.

For patients with asthma or COPD, PL554 has the potential to both reverse bronchodilation and reduce inflammation more quickly and with fewer adverse effects.

Patients respond to 5 days of corticosteroid therapy just as well as to 14 days of therapy, according to a study.

Emphysematous cholecystitis is a rare condition that is the result of infection with Clostridium perfringens and other gas-producing organisms including Escherichia coli, Bacteroides fragilis, and Klebsiella species.

Older patients with chronic obstructive pulmonary disease are at higher risk for plaque formation in the carotid artery, increasing their risk of stroke.

Diagnoses of chronic obstructive pulmonary disease may increase with the use of a 5-question patient-administered survey.

Pages

Subscribe to
Please Wait 20 seconds or click here to close